Varian Medical Systems, Inc. (VAR) Insider Sells $1,452,892.32 in Stock

Varian Medical Systems, Inc. (NYSE:VAR) insider Dow R. Wilson sold 15,059 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $96.48, for a total value of $1,452,892.32. Following the completion of the transaction, the insider now directly owns 81,835 shares in the company, valued at $7,895,440.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Varian Medical Systems, Inc. (NYSE VAR) traded up 1.25% during trading on Friday, hitting $100.50. The stock had a trading volume of 1,053,948 shares. The company has a market cap of $9.23 billion, a PE ratio of 33.08 and a beta of 0.61. The company’s 50 day moving average is $101.14 and its 200-day moving average is $94.15. Varian Medical Systems, Inc. has a 12 month low of $75.20 and a 12 month high of $107.08.

Varian Medical Systems (NYSE:VAR) last released its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The firm had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $663.86 million. During the same period in the previous year, the firm posted $1.00 EPS. Varian Medical Systems’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, equities research analysts predict that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by BNB Daily and is owned by of BNB Daily. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.baseball-news-blog.com/2017/08/19/varian-medical-systems-inc-var-insider-dow-r-wilson-sells-15059-shares-updated.html.

A number of hedge funds have recently made changes to their positions in VAR. First Mercantile Trust Co. increased its stake in Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock valued at $100,000 after buying an additional 25 shares during the last quarter. Manchester Capital Management LLC increased its stake in Varian Medical Systems by 16.5% in the second quarter. Manchester Capital Management LLC now owns 1,057 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 150 shares during the last quarter. Parallel Advisors LLC increased its stake in Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock valued at $113,000 after buying an additional 176 shares during the last quarter. Heritage Trust Co purchased a new stake in Varian Medical Systems during the first quarter valued at $118,000. Finally, Penserra Capital Management LLC increased its stake in Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock valued at $146,000 after buying an additional 140 shares during the last quarter. 98.95% of the stock is owned by institutional investors.

A number of research analysts recently commented on VAR shares. BidaskClub cut Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Off Wall Street started coverage on Varian Medical Systems in a report on Monday, April 24th. They set a “sell” rating on the stock. Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Citigroup Inc. raised Varian Medical Systems from a “neutral” rating to a “buy” rating in a report on Monday, May 15th. Finally, Jefferies Group LLC reaffirmed a “buy” rating on shares of Varian Medical Systems in a report on Thursday, May 11th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. Varian Medical Systems currently has a consensus rating of “Hold” and an average target price of $96.28.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply